Rosenthal, M A <br/><br/>
Phase II clinical trial of recombinant alpha-2 interferon for biopsy-proven metastatic or recurrent renal carcinoma.  [electronic resource] 

 -  British journal of urology  May 1992 
 - 491-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1331 
<br/><br/><label>Standard No.: </label>10.1111/j.1464-410x.1992.tb15594.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Interferon Type I--adverse effects<br/>Kidney Neoplasms--secondary<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--therapy<br/>Recombinant Proteins<br/>Treatment Outcome